{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:27:50Z","timestamp":1761744470876,"version":"3.41.2"},"reference-count":33,"publisher":"Portland Press Ltd.","issue":"2","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":818,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,30]]},"abstract":"<jats:p>It is still not entirely clear how \u03b1-galactosidase A (GAA) deficiency translates into clinical symptoms of Fabry disease (FD). The present communication investigates the effects of the mutation N215S in FD on the trafficking and processing of lysosomal GAA and their potential association with alterations in the membrane lipid composition. Abnormalities in lipid rafts (LRs) were observed in fibroblasts isolated from a male patient with FD bearing the mutation N215S. Interestingly, LR analysis revealed that the distribution of cholesterol and flotillin-2 are distinctly altered in the Fabry fibroblasts when compared with that of the wild-type cells. Furthermore, increased levels of glycolipid globotriaosylceramide 3 (Gb3) and sphingomyelin (SM) were observed in non-raft membrane fractions of Fabry cells. Substrate reduction with N-butyldeoxynojirimycin (NB-DNJ) in vitro was capable of reversing these abnormalities in this patient. These data led to the hypothesis that alterations of LRs may contribute to the pathophysiology of Morbus Fabry. Furthermore, it may be suggested that substrate reduction therapy with NB-DNJ might be a promising approach for the treatment of GAA deficiency at least for the selected patients.<\/jats:p>","DOI":"10.1042\/bsr20160402","type":"journal-article","created":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T00:10:15Z","timestamp":1490746215000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Case study on the pathophysiology of Fabry disease: abnormalities of cellular membranes can be reversed by substrate reduction <i>in vitro<\/i>"],"prefix":"10.1042","volume":"37","author":[{"given":"Graham","family":"Brogden","sequence":"first","affiliation":[{"name":"Department of Physiological Chemistry, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hannover, Germany"},{"name":"Fish Disease Research Unit, University of Veterinary Medicine Hannover, Buenteweg 17, D-30559 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeel","family":"Shammas","sequence":"additional","affiliation":[{"name":"Department of Physiological Chemistry, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hannover, Germany"},{"name":"Department of Paediatrics, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Maalouf","sequence":"additional","affiliation":[{"name":"Department of Physiological Chemistry, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hannover, Germany"},{"name":"Department of Paediatrics, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samara\u00a0L.","family":"Naim","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany"},{"name":"Faculty of Science, University of Fribourg, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabi","family":"Wetzel","sequence":"additional","affiliation":[{"name":"Department of Physiological Chemistry, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Amiri","sequence":"additional","affiliation":[{"name":"Department of Physiological Chemistry, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maren","family":"von K\u00f6ckritz-Blickwede","sequence":"additional","affiliation":[{"name":"Department of Physiological Chemistry, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anibh\u00a0M.","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan\u00a0Y.","family":"Naim","sequence":"additional","affiliation":[{"name":"Department of Physiological Chemistry, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2017,4,28]]},"reference":[{"key":"2021111619091501800_B1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","article-title":"The molecular defect leading to Fabry disease: structure of human alpha-galactosidase","volume":"337","author":"Garman","year":"2004","journal-title":"J. Mol. Biol."},{"key":"2021111619091501800_B2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J. Med. Genet."},{"key":"2021111619091501800_B3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1012447102358","article-title":"Natural history of Fabry disease in affected males and obligate carrier females","volume":"24","author":"MacDermot","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"2021111619091501800_B4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1010331404448","article-title":"Enzyme replacement and beyond","volume":"24","author":"Desnick","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"2021111619091501800_B5","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111619091501800_B6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10545-006-0196-0","article-title":"Manifestations of Fabry disease in placental tissue","volume":"29","author":"Vedder","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"2021111619091501800_B7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10545-010-9114-6","article-title":"A modified lipid composition in Fabry disease leads to an intracellular block of the detergent-resistant membrane-associated dipeptidyl peptidase IV","volume":"33","author":"Maalouf","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"2021111619091501800_B8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.biophys.32.110601.141803","article-title":"Model systems, lipid rafts, and cell membranes","volume":"33","author":"Simons","year":"2004","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"2021111619091501800_B9","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1016\/j.yexcr.2009.07.020","article-title":"Domains in biological membranes","volume":"315","author":"Lindner","year":"2009","journal-title":"Exp. Cell. Res."},{"key":"2021111619091501800_B10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbamem.2013.07.018","article-title":"Interaction of membrane\/lipid rafts with the cytoskeleton: impact on signaling and function: membrane\/lipid rafts, mediators of cytoskeletal arrangement and cell signaling","volume":"1838","author":"Head","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"2021111619091501800_B11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biochi.2016.09.011","article-title":"Alterations in membrane trafficking and pathophysiological implications in lysosomal storage disorders","volume":"130","author":"Kuech","year":"2016","journal-title":"Biochimie"},{"key":"2021111619091501800_B12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"2021111619091501800_B13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10545-014-9725-4","article-title":"Long term differential consequences of miglustat therapy on intestinal disaccharidases","volume":"37","author":"Amiri","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"2021111619091501800_B14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1042\/bj2410427","article-title":"Biosynthesis and maturation of lactase-phlorizin hydrolase in the human small intestinal epithelial cells","volume":"241","author":"Naim","year":"1987","journal-title":"Biochem. J."},{"key":"2021111619091501800_B15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/BJ20070396","article-title":"Different glycoforms of prostate-specific membrane antigen are intracellularly transported through their association with distinct detergent-resistant membranes","volume":"409","author":"Castelletti","year":"2008","journal-title":"Biochem. J."},{"key":"2021111619091501800_B16","first-page":"4055","article-title":"Constitutive and antibody-induced internalization of prostate-specific membrane antigen","volume":"58","author":"Liu","year":"1998","journal-title":"Cancer Res."},{"key":"2021111619091501800_B17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1083\/jcb.101.3.838","article-title":"Expression and intracellular transport of microvillus membrane hydrolases in human intestinal epithelial cells","volume":"101","author":"Hauri","year":"1985","journal-title":"J. Cell Biol."},{"key":"2021111619091501800_B18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cbpb.2013.12.001","article-title":"Isolation and analysis of membrane lipids and lipid rafts in common carp (Cyprinus carpio L.)","volume":"169","author":"Brogden","year":"2014","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"key":"2021111619091501800_B19","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1073\/pnas.79.15.4540","article-title":"endo-beta-N-acetylglucosaminidase F: endoglycosidase from Flavobacterium meningosepticum that cleaves both high-mannose and complex glycoproteins","volume":"79","author":"Elder","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111619091501800_B20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1432-1033.1987.tb11438.x","article-title":"Signal sequence and DNA-mediated expression of human lysosomal alpha-galactosidase A","volume":"165","author":"Tsuji","year":"1987","journal-title":"Eur. J. Biochem."},{"key":"2021111619091501800_B21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20070479","article-title":"Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin","volume":"406","author":"Ishii","year":"2007","journal-title":"Biochem. J."},{"key":"2021111619091501800_B22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrm2977","article-title":"Revitalizing membrane rafts: new tools and insights","volume":"11","author":"Simons","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2021111619091501800_B23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1096\/fj.04-2375com","article-title":"A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder","volume":"19","author":"Yam","year":"2005","journal-title":"FASEB J."},{"key":"2021111619091501800_B24","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood.V97.4.1141","article-title":"Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts","volume":"97","author":"Salzer","year":"2001","journal-title":"Blood"},{"key":"2021111619091501800_B25","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1194\/jlr.M500103-JLR200","article-title":"Domain-specific lipid distribution in macrophage plasma membranes","volume":"46","author":"Gaus","year":"2005","journal-title":"J. Lipid Res."},{"key":"2021111619091501800_B26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jcp.21623","article-title":"Biochemical characterization of membrane fractions in murine sperm: identification of three distinct sub-types of membrane rafts","volume":"218","author":"Asano","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"2021111619091501800_B27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0957-4166(99)00468-1","article-title":"Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis","volume":"11","author":"Butters","year":"2000","journal-title":"Tetrahedron: Asymmetry"},{"key":"2021111619091501800_B28","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.2174\/1381612811319330016","article-title":"Anderson Fabry disease: a multiorgan metabolic disease susceptible of treatment","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"2021111619091501800_B29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ymgme.2013.10.010","article-title":"Altered dynamics of a lipid raft associated protein in a kidney model of Fabry disease","volume":"111","author":"Labilloy","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"2021111619091501800_B30","doi-asserted-by":"crossref","first-page":"8500","DOI":"10.1073\/pnas.1404582111","article-title":"Membrane raft association is a determinant of plasma membrane localization","volume":"111","author":"Diaz-Rohrer","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111619091501800_B31","doi-asserted-by":"crossref","first-page":"e36373","DOI":"10.1371\/journal.pone.0036373","article-title":"Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease","volume":"7","author":"Namdar","year":"2012","journal-title":"PLoS ONE"},{"key":"2021111619091501800_B32","doi-asserted-by":"crossref","first-page":"20960","DOI":"10.1074\/jbc.M702436200","article-title":"Caveolin-associated accumulation of globotriaosylceramide in the vascular endothelium of alpha-galactosidase A null mice","volume":"282","author":"Shu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2021111619091501800_B33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1510198","article-title":"Treatment of Fabry\u2019s disease with the pharmacologic chaperone migalastat","volume":"375","author":"Germain","year":"2016","journal-title":"N. Engl. J. Med."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20160402\/519096\/bsr-2016-0402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20160402\/519096\/bsr-2016-0402.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T19:58:24Z","timestamp":1637092704000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/37\/2\/BSR20160402\/83009\/Case-study-on-the-pathophysiology-of-Fabry-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,28]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4,30]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20160402","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"type":"print","value":"0144-8463"},{"type":"electronic","value":"1573-4935"}],"subject":[],"published":{"date-parts":[[2017,4,28]]},"article-number":"BSR20160402"}}